Clinical Trial Update: Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)? [NA]

View source ↗

Summary

This clinical trial examining whether VEGF or CFH gene polymorphisms influence response to VEGF inhibitors in choroidal neovascularization and age-related macul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Snippet

Sponsor: Medical University of Vienna | Conditions: Choroidal NeoVascularization, Age-Related Macular Degeneration | NA | Status: WITHDRAWN